BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20102031)

  • 41. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
    Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
    Carmagnola D; Celestino S; Abati S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
    Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G
    J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studying the role of microcracks in the pathophysiology of BRONJ.
    Allen MR
    Clin Oral Investig; 2009 Dec; 13(4):481-2; author reply 483-4. PubMed ID: 19688226
    [No Abstract]   [Full Text] [Related]  

  • 45. Novel hypotheses in the etiopathogenesis of bisphosphonate-related osteonecrosis of the jaws.
    Kyrgidis A
    J Oral Maxillofac Surg; 2009 Nov; 67(11):2554. PubMed ID: 19837341
    [No Abstract]   [Full Text] [Related]  

  • 46. Osteonecrosis of the jaw related to bevacizumab.
    Estilo CL; Fornier M; Farooki A; Carlson D; Bohle G; Huryn JM
    J Clin Oncol; 2008 Aug; 26(24):4037-8. PubMed ID: 18711196
    [No Abstract]   [Full Text] [Related]  

  • 47. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse oral sequelae to bisphosphonate administration.
    Marunick M; Miller R; Gordon S
    J Mich Dent Assoc; 2005 Nov; 87(11):44-9. PubMed ID: 16372548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Osteonecrosis and bisphosphonates: correlation versus causation.
    Schwartz HC
    J Oral Maxillofac Surg; 2004 Jun; 62(6):763-4. PubMed ID: 15181903
    [No Abstract]   [Full Text] [Related]  

  • 50. Denosumab an option for patients with bone metastasis from breast cancer.
    Barton MK
    CA Cancer J Clin; 2011; 61(3):135-6. PubMed ID: 21532096
    [No Abstract]   [Full Text] [Related]  

  • 51. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data.
    Allen MR; Burr DB
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):61-70. PubMed ID: 19371816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Osteonecrosis of the jaw and bisphophonates in oncology].
    Facon T; Bensadoun RJ; Blanc JL; Confavreux C; Gourmet R; Maes JM; Penel G; Vieillard MH; Woeller A
    Bull Cancer; 2008 Apr; 95(4):413-8. PubMed ID: 18495570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.
    Kang HS; Lee JW; Kim JS
    Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drugs for postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2008 Oct; 6(74):67-74; quiz 75-6. PubMed ID: 18800025
    [No Abstract]   [Full Text] [Related]  

  • 55. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New cancer therapies and jaw necrosis.
    Patel V; Kelleher M; Sproat C; Kwok J; McGurk M
    Br Dent J; 2015 Sep; 219(5):203-7. PubMed ID: 26361116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 58. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
    Reid IR; Bolland MJ; Grey AB
    Bone; 2007 Sep; 41(3):318-20. PubMed ID: 17572168
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.
    Landesberg R; Wilson T; Grbic JT
    Dent Today; 2006 Aug; 25(8):52, 54-7. PubMed ID: 16925161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Osteonecrosis of the jaw].
    Eriksen EF
    Ugeskr Laeger; 2009 Feb; 171(8):629; author reply 629. PubMed ID: 19291862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.